Anuh Pharma Stock Screener | Share Price & Fundamental Analysis
ANUHPHR
Pharmaceuticals
Share Price NSE
₹74.99
▼
-0.87 (-1.15%)
Share Price BSE
₹75.11
▼
-0.85 (-1.12%)
Track Anuh Pharma share price live with TickJournal's free stock screener.
Analyze Anuh Pharma share price history trends and compare 52-week high low
levels.
Calculate ANUHPHR stock fair value using fundamental analysis and view live share price charts.
Determine Anuh Pharma share intrinsic value and compare it with current ANUHPHR share price.
Record your Anuh Pharma trades in TickJournal's free trading journal and track your portfolio performance.
Anuh Pharma Market Cap
₹812.62 Cr.
ANUHPHR P/E Ratio (TTM)
19.42
EPS (TTM)
₹9.45
Dividend Yield
0.93%
Debt to Equity
0.02
ANUHPHR 52 Week High
₹110.40
Anuh Pharma 52 Week Low
₹71.02
Operating Margin
8.00%
Profit Margin
5.40%
ANUHPHR Revenue (TTM)
₹778.00
EBITDA
₹68.00
Net Income
₹42.00
Total Assets
₹507.00
Total Equity
₹326.00
Anuh Pharma Share Price History - Stock Screener Chart
Screen ANUHPHR historical share price movements with interactive charts. Analyze price trends and patterns.
Anuh Pharma Company Profile - Fundamental Screener
Screen Anuh Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ANUHPHR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE489G01022
Anuh Pharma Balance Sheet Screener
Screen ANUHPHR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 507 | 446 | 405 | 347 | 333 | 326 | 240 | 209 | 189 | 193 |
| Current Assets | 376 | 339 | 308 | 259 | 238 | 223 | 152 | 154 | 138 | 151 |
| Fixed Assets | 58 | 49 | 53 | 61 | 71 | 84 | 21 | 17 | 17 | 18 |
| Liabilities | ||||||||||
| Total Liabilities | 507 | 446 | 405 | 347 | 333 | 326 | 240 | 209 | 189 | 193 |
| Current Liabilities | 2 | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 326 | 291 | 241 | 214 | 191 | 162 | 165 | 150 | 141 | 119 |
| Share Capital | 25 | 25 | 25 | 25 | 25 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 301 | 266 | 216 | 189 | 166 | 150 | 152 | 137 | 128 | 107 |
Anuh Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Anuh Pharma income statement and profit fundamentals.
Analyze ANUHPHR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Anuh Pharma share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 778 | 671 | 659 | 534 | 492 | 443 | 311 | 325 | 246 | 214 | 330 | 289 |
| Expenses | 710 | 601 | 572 | 476 | 440 | 387 | 284 | 291 | 220 | 184 | 290 | 254 |
| EBITDA | 68 | 70 | 87 | 57 | 52 | 55 | 27 | 34 | 25 | 30 | 40 | 35 |
| Operating Profit % | 8.00% | 9.00% | 12.00% | 10.00% | 10.00% | 10.00% | 7.00% | 9.00% | 8.00% | 11.00% | 11.00% | 11.00% |
| Depreciation | 11 | 9 | 9 | 10 | 12 | 15 | 7 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 56 | 61 | 78 | 48 | 39 | 39 | 19 | 32 | 23 | 28 | 38 | 32 |
| Tax | 16 | 14 | 18 | 11 | 9 | 10 | 5 | 9 | 7 | 8 | 12 | 10 |
| Net Profit | 42 | 47 | 60 | 36 | 31 | 28 | 14 | 23 | 17 | 20 | 26 | 22 |
| EPS | 6.20 | 9.45 | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 9.33 | 6.59 | 8.00 | 10.30 | 8.78 |
Anuh Pharma Cash Flow Screener - Liquidity Fundamentals
Screen ANUHPHR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 37 | 13 | 54 | 29 | -19 | 49 | 7 | 2 | 26 | 17 |
| Investing Activities | -20 | 1 | -44 | -8 | 52 | -77 | 3 | 2 | -20 | -5 |
| Financing Activities | -5 | -9 | -12 | -20 | -33 | 22 | -7 | -5 | -4 | -9 |
| Net Cash Flow | 12 | 5 | -2 | 2 | 0 | -5 | 4 | -1 | 2 | 2 |
Anuh Pharma Shareholding Pattern Screener
See Anuh Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Anuh Pharma promoter holding and ownership changes for ANUHPHR on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jul | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.82% | 71.82% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% |
| FII Holding | 0.00% | 0.00% | 0.03% | 0.04% | 0.04% | 0.02% | 0.02% | 0.03% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.74% | 23.86% | 25.83% | 25.89% | 25.92% | 26.02% | 26.27% | 26.30% |
| Other Holding | 4.44% | 4.33% | 4.23% | 4.16% | 4.13% | 4.04% | 3.79% | 3.75% |
| Shareholder Count | 27,889 | 28,250 | 26,157 | 24,257 | 24,235 | 24,048 | 23,910 | 23,494 |
Anuh Pharma Share Dividend Screener - Share Yield Analysis
Check Anuh Pharma dividend history with payout and yield data.
View Anuh Pharma dividend details including ex-dates and amounts for ANUHPHR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 1.85% |
| 2024-March | ₹2.50 | 3.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Anuh Pharma Stock Index Membership
See which indices include Anuh Pharma stock.
Check ANUHPHR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Anuh Pharma Market Events Screener - Corporate Actions
Get Anuh Pharma corporate actions including splits, bonuses, and buybacks.
Check Anuh Pharma stock events that may affect ANUHPHR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Bonus | 1:1 | 13.69% | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 7.85% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -3.79% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | -13.23% |
| 2025-08-14 | 2025-08-15 | Dividend | ₹ 1.50 /share | -16.76% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -7.61% |
| 2025-07-15 | 2025-07-15 | Bonus | 1:1 | -5.91% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 17.41% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 5.24% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 5.11% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -12.70% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 2.50 /share | -13.94% |
| 2023-08-11 | 2023-08-11 | Dividend | ₹ 2.00 /share | 40.69% |
| 2022-08-03 | 2022-08-05 | Dividend | ₹ 1.75 /share | 9.43% |
| 2021-08-17 | 2021-08-19 | Dividend | ₹ 1.50 /share | -19.74% |
Anuh Pharma Competitors Screener - Peer Comparison
Screen ANUHPHR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 408,007 | 37.20 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 163,250 | 66.07 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 144,229 | 64.43 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 109,566 | 23.71 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 105,948 | 19.16 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 101,478 | 21.52 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,613 | 18.12 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 86,000 | 47.17 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 68,802 | 19.14 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 65,528 | 26.80 | 13,458 | 3.70% | 2,216 | 40.44 |
Anuh Pharma Company Announcements - News Screener
Screen ANUHPHR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-12 | Announcement Under Regulation 30 (LODR) - Completion Of United States Food And Drug Administration (USFDA) Inspection With No Form 483 Observations Issued | View |
| 2026-02-12 | Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events. | View |
| 2026-02-12 | Results-Financial Results For December 31 2025 | View |
| 2026-02-12 | Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 06/02/2026 | View |
| 2026-02-02 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St December 2025. | View |
| 2026-01-21 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR) | View |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-05 | Announcement Under Regulation 30 (LODR) - Updates | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Announcement Under Regulation 30 (LODR) - Adoption Of Revised Polices And Codes | View |
| 2025-11-07 | Results-Financial Results For September 30 2025 | View |
| 2025-11-07 | Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/11/2025 | View |
| 2025-10-31 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-16 | Announcement under Regulation 30 (LODR)-Credit Rating | View |